SearchInput the word you want to find
- ABOUT JSMO
- HOME
- ABOUT JSMO
- 2023 Award Recipients
2023 Award Recipients
2023 Award Recipients
| Annals of Oncology | ||
|---|---|---|
| Name | Affiliation | Awarded Paper |
| Kohei Shitara | Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East |
REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients https://www.sciencedirect.com/science/article/pii/S0923753419310336 |
| Young Investigator Award | ||
| Name | Affiliation | Title |
| Taisuke Ishii | National Cancer Center | Differences in the administration of adjuvant chemotherapy between patients with and without chronic kidney disease |
| Hiraku Ogata | Department of Hematology, National Cancer Center Hospital East |
Clinical adaptability of HSP90 inhibitor in refractory AML based on genetic mutation |
| Tatsunori Suzuki | Department of Gastroenterology,vGraduate School of Medicine, The University of Tokyo, The GTK Pancreatic Cancer Study Group |
Major driver genes in relation to postoperative recurrence, treatment response, and survival among patients with pancreatic cancer |
| Junko Tanizaki | Department of Medical Oncology, Kindai University Faculty of Medicine |
Nivolumab for cancer of unknown primary (CUP): Initial results from an expanded access program (NivoCUP2, WJOG14620M) |
| Ren Toriumi | Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medicical Science |
Subgroup analysis with testosterone level: androgen replacement therapy for cancer-related symptoms in male; prospective randomized trial (ARTFORM study) |
| Takeshi Hirose | 1Department of Orthopaedic Surgery, Graduate School of Medicine, Kyushu University Division of Cellular Signaling, National Cancer Center Research Institute |
Extensive evaluation of the function and drug sensitivity in 58 sarcoma-related fusion genes |
| Eriko Murakami | Internal Medicine III, Wakayama Medical University |
Randomized phase II trial of furosemide vs mannitol in short-hydration CDDP-based chemotherapy for thoracic malignancies |
| Keiichiro Mori | Department of Urology, The Jikei University School of Medicine |
Preoperative blood-based biomarker panel for prediction of oncological outcomes after radical cystectomy |
| Sena Yamamoto | Osaka University Graduate School of Medicine, Division of Health Sciences |
Financial toxicity and cost-related experience in molecular and immune therapies: A multicenter questionnaire survey |
| Yung-Yeh Su | National Health Research Institute, Tainan, Taiwan,National Cheng-Kung University Hospital, Tainan, Taiwan |
Nivolumab plus ipilimumab (N+I) for potentially resectable hepatocellular carcinoma (HCC): efficacy and surgical outcome |
※Titles omitted, listed in Japanese alphabetical order.
※Affiliations are listed as of the time of the award.
Scenes from the Award Ceremony
※Click to view a larger image.
©Japanese Society of Medical Oncology All rights reserved.